CD44 and nasopharyngeal carcinoma: To test whether NPC cells developed MDR because of the selection of an innate paclitaxel-resistant subgroup, we tested the IC50 of CNE2TR-CD44+ cells and CNE2-CD44+ cells compared with parental CNE2TR cells and CNE2 cells.